This series of BIA Brexit Briefings will provide monthly updates for our UK and International audiences answering 'What does Brexit mean for Biotechnology and the UK and beyond?'
Following the outcome of the UK’s referendum on membership of the European Union, the BIA has worked closely with members and stakeholders to identify the threats and opportunities for biotech post-Brexit and to represent the sector.
Our BIA Brexit Briefing webinars will provide a monthly update on government policy, progress of working groups, and how these will potentially affect companies in life sciences – particularly with regards to innovation, financing, regulation and people.
Join us in June, where in addition to our standard Brexit briefing, we will also be providing an analysis of the outcome of the 2017 General Election and how this impacts the UK life sciences sector generally and how it relates to the ongoing work of both government and industry on Brexit.
BIA 2017 Supporters